External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience Cure SMA 2021
Roche and Genentech at

Cure SMA 2021

June 07 - June 11
Virtual
curesma.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Highlights
Coming soon
02:00 PM
Duration 15mins Virtual
JEWELFISH: Safety, pharmacodynamic and exploratory efficacy data in non-naïve patients with spinal muscular atrophy (SMA) receiving treatment with risdiplam▼
Chiriboga CA*, Bruno C, Duong T, Fischer D, Kirschner J, Mercuri E, Gerber M, Gorni K, Kletzl H, Carruthers I, Martin C, Warren F, Scoto M on behalf of the JEWELFISH Study Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 15mins Virtual
RAINBOWFISH: A study of risdiplam▼ in infants with presymptomatic spinal muscular atrophy (SMA)
Finkel RS*, Al-Muhaizea M, Farrar MA, Nelson L, Prufer A, Servais L, Wang Y, Zanoteli E, El-Khairi M, Gerber M, Gorni K, Kletzl H, Palfreeman L, Scalco RS, Bertini E on behalf of the RAINBOWFISH Study Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

Sign up or login to unlock the full suite of MEDICALLY features
2021 Cure SMA Annual Conference In-Depth Report
Springer Healthcare
Open asset

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.